Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
Salary for this Role: From £47,500 with benefits, subject to skills and experience Application Deadline: Thursday 6th August 2026 at 11.55pm About us The Francis Crick Institute is Europe’s largest
-
: From £47,080 with benefits, subject to skills and experience About us The Francis Crick Institute is Europe’s largest biomedical research institute under one roof. Our world-class scientists and staff
-
for this Role: From £47,500 with benefits, subject to skills and experience Application Deadline: 6th July 2026 at 11.55pm About us The Francis Crick Institute is Europe’s largest biomedical research institute
-
Cancer Medicine and the Barts NHS Trust to achieve improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick
-
world‑leading or internationally excellent. Our research is supported by strong national and international partnerships, including with the Francis Crick Institute. School of Life Course & Population
-
interfaces. Experience working within interdisciplinary research, translational biology, biotech, drug discovery or platform-development environments. About us The Francis Crick Institute is Europe’s largest
-
interdisciplinary or translational research environments. Experience preparing SOPs, validation documentation or training materials. About us The Francis Crick Institute is Europe’s largest biomedical research
-
. We are collegial. We show respect for one another, work cooperatively and support the wider community. At the Francis Crick Institute, we believe that diversity and inclusion are essential to driving
-
, including the UCL Centre for Integrative Anatomy and the UCL Consortium for Mitochondrial Research. Close links also exist to the Francis Crick Institute, the Natural History Museum and the Sainsbury-Wellcome
-
top universities and a founding member of the Francis Crick Institute. The Institute draws together over 400 scientists working together to develop world-class basic and translational cancer research